Norbert Pescosta

3.3k total citations
23 papers, 614 citations indexed

About

Norbert Pescosta is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Norbert Pescosta has authored 23 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 11 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Norbert Pescosta's work include Multiple Myeloma Research and Treatments (17 papers), Cancer Treatment and Pharmacology (8 papers) and Protein Degradation and Inhibitors (5 papers). Norbert Pescosta is often cited by papers focused on Multiple Myeloma Research and Treatments (17 papers), Cancer Treatment and Pharmacology (8 papers) and Protein Degradation and Inhibitors (5 papers). Norbert Pescosta collaborates with scholars based in Italy, Austria and Germany. Norbert Pescosta's co-authors include Mario Boccadoro, Pellegrino Musto, Claudia Crippa, Antonio Palumbo, Tommaso Caravita, Patrizia Falco, Ilaria Avonto, Mónica Galli, Giulia Benevolo and Vincenzo Callea and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Norbert Pescosta

23 papers receiving 594 citations

Peers

Countries citing papers authored by Norbert Pescosta

Since Specialization

Citations

This map shows the geographic impact of Norbert Pescosta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Pescosta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Pescosta more than expected).

Fields of papers citing papers by Norbert Pescosta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert Pescosta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Pescosta. The network helps show where Norbert Pescosta may publish in the future.

Co-authorship network of co-authors of Norbert Pescosta

This figure shows the co-authorship network connecting the top 25 collaborators of Norbert Pescosta. A scholar is included among the top collaborators of Norbert Pescosta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norbert Pescosta. Norbert Pescosta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ixazomib-Based Induction Followed By Single-Agent Ixazomib Maintenance in Transplant Ineligible, Newly Diagnosed Multiple Myeloma Patients: Updated Results of the EMN10-Unito Trial 2020 ·Blood ·Roberto Mina, Alessandra Larocca, Paolo Corradini, Nicola Cascavilla, Anna Marina Liberati, Norbert Pescosta, Francesca Fazio, Giovannino Ciccone, Andréa Capra, Francesca Patriarca, Annalisa Bernardini, Delia Rota Scalabrini, Michele Cea, Renato Zambello, Anna Baraldi, Angelo Belotti, Mario Boccadoro, Sara Bringhen	3
2	In Multiple Myeloma, Minimal Residual Disease (MRD) Is an Early Predictor of Progression and Is Modulated By Maintenance Therapy with Lenalidomide 2014 ·Blood ·Manuela Gambella, Paola Omedè, Stefania Oliva, Milena Gilestro, (unknown), Daniela Drandi, Simone Ferrero, Francesca Gay, Francesca Patriarca, (unknown), Maria Teresa Petrucci, Norbert Pescosta, Anna Marina Liberati, Tommaso Caravita, Francesco Di Raimondo, Alberto Rocci, Pellegrino Musto, Mario Boccadoro, Antonio Palumbo	2
3	Persistent Improvement In Clinical Outcomes With Bortezomib-Thalidomide-Dexamethasone Vs Thalidomide-Dexamethasone Incorporated Into Double Autologous Transplantation For Multiple Myeloma: An Updated Analysis Of Phase 3 Gimema-MMY-3006 Study 2013 ·Blood ·Michèle Cavo, Mónica Galli, Annalisa Pezzi, Francesco Di Raimondo, Claudia Crippa, Massimo Offidani, Paola Tacchetti, Vittorio Montefusco, Franco Narni, Antonio Spadano, Norbert Pescosta, Elena Zamagni, Barbara Gamberi, Tommaso Caravita, Antonietta Falcone, Chiara Nozzoli, Renato Zambello, Anna Furlan, Annamaria Brioli, Mario Boccadoro	6
4	Bortezomib As Induction Before Autologous Transplantation, Followed by Lenalidomide As Consolidation-Maintenance in Untreated Multiple Myeloma Patients 2010 ·Journal of Clinical Oncology ·Antonio Palumbo, Francesca Gay, Patrizia Falco, Claudia Crippa, Vittorio Montefusco, Francesca Patriarca, Fausto Rossini, S Caltagirone, Giulia Benevolo, Norbert Pescosta, Tommasina Guglielmelli, Sara Bringhen, Massimo Offidani, Nicola Giuliani, Maria Teresa Petrucci, Pellegrino Musto, Anna Marina Liberati, Giuseppe Rossi, Paolo Corradini, Mario Boccadoro	114
5	A Phase III Study of Enoxaparin Vs Aspirin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Lenalidomide-Based Regimen. 2010 ·Blood ·Federica Cavallo, Francesco Di Raimondo, (unknown), Barbara Lupo, Alessandra Romano, Lucio Catalano, Luca Baldini, Tommasina Guglielmelli, Luciano Masini, Davide Rossi, Roberto Ria, Giulia Benevolo, Antonietta Falcone, Norbert Pescosta, Mónica Galli, Anna Baraldi, Valter Redoglia, Mario Boccadoro, Antonio Palumbo	8
6	A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma 2009 ·Annals of Hematology ·Mónica Galli, Silvia Salmoiraghi, Josée Golay, Antonella Gozzini, Claudia Crippa, Norbert Pescosta, Alessandro Rambaldi	92
7	Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma 2008 ·Annals of Oncology ·Antonio Palumbo, Francesca Gay, Sara Bringhen, Antonietta Falcone, Norbert Pescosta, Vincenzo Callea, Tommaso Caravita, Fortunato Morabito, Valeria Magarotto, Marina Ruggeri, Ilaria Avonto, Pellegrino Musto, Nicola Cascavilla, Benedetto Bruno, Mario Boccadoro	85
8	Factors predictive of outcome in relapsed, refractory multiple myeloma patients treated with bortezomib, melphalan, prednisone, and thalidomide (VMPT) 2007 ·Journal of Clinical Oncology ·Antonio Palumbo, (unknown), (unknown), Norbert Pescosta, Vincenzo Callea, Clotilde Cangialosi, Tommaso Caravita, Francesco Carlo Morabito, Francesca Gay, Mario Boccadoro	1
9	Bortezomib, Pegylated-Lyposomal-Doxorubicin and Dexamethasone Followed by Melphalan 100 mg/m2 in Elderly Newly Diagnosed Patients: An Interim Analysis. 2007 ·Blood ·Antonio Palumbo, Ilaria Avonto, Francesca Patriarca, Claudia Crippa, Maria Teresa Petrucci, Fausto Rossini, Paolo Corradini, Anna Marina Liberati, Nicola Giuliani, Norbert Pescosta, Patrizia Falco, Alessandra Larocca, Paola Omedè, Massimo Offidani, Renato Fanin, Mario Boccadoro	9
10	A Phase II Multiple Dose Clinical Trial of Histone Deacetylase Inhibitor ITF2357 in Patients with Relapsed or Progressive Multiple Myeloma: Preliminary Results. 2007 ·Blood ·Mónica Galli, Silvia Salmoiraghi, Josée Golay, Antonella Gozzini, Alberto Bosi, Claudia Crippa, Giuseppe Rossi, Norbert Pescosta, Sergio Cortelazzo, (unknown), (unknown), Alessandro Rambaldi	13
11	Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma 2006 ·Blood ·Antonio Palumbo, Maria Teresa Ambrosini, Giulia Benevolo, Patrizia Pregno, Norbert Pescosta, Vincenzo Callea, Clotilde Cangialosi, Tommaso Caravita, Fortunato Morabito, Pellegrino Musto, Sara Galimberti, Patrizia Falco, Ilaria Avonto, Federica Cavallo, Mario Boccadoro, (unknown)	137
12	Combination of Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) for Relapsed Multiple Myeloma: Results of a Phase I/II Clinical Trial. 2006 ·Blood ·Antonio Palumbo, Maria Teresa Ambrosini, Giulia Benevolo, Patrizia Pregno, Norbert Pescosta, Vincenzo Callea, Clotilde Cangialosi, Tommaso Caravita, Fortunato Morabito, Pellegrino Musto, Sara Galimberti, Francesca Gay, Cecilia Rus, Mario Boccadoro	5
13	Velcade™ Plus Melphalan, Prednisone, and Thalidomide (V-MPT) for Advanced Multiple Myeloma. 2005 ·Blood ·Antonio Palumbo, Maria Teresa Ambrosini, Patrizia Pregno, Norbert Pescosta, Vincenzo Callea, Clotilde Cangialosi, Tommaso Caravita, Fortunato Morabito, Paola Omedè, Francesca Gay, Ilaria Avonto, Patrizia Falco, Sara Bringhen, Mario Boccadoro	10
14	TWO DOSE-INTENIVE MELPHALAN REGIMENS (100 MG/M2 VERSUS 200 MG/M2) IN MULTIPLE MYELOMA PATIENTS 2003 ·Haematologica ·Sara Bringhen, Alessandra Bertola, Federica Cavallo, (unknown), Massimo Massaia, Benedetto Bruno, Anna Maria Barbui, Tommaso Caravita, P. Musto, Norbert Pescosta, Fausto Rossini, Marco Vignetti, Mario Boccadoro, Antonio Palumbo	12
15	T‐cell receptor excision circles: a novel prognostic parameter for the outcome of transplantation in multiple myeloma patients 2003 ·British Journal of Haematology ·Mirija Svaldi, (unknown), Martin Dugas, Peter Lohse, Norbert Pescosta, Christian Straka, Manfred Mitterer	22
16	Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m2) 2003 ·Leukemia ·Antonio Palumbo, (unknown), Alessandra Bertola, Federica Cavallo, (unknown), Massimo Massaia, Benedetto Bruno, (unknown), Anna Maria Barbui, Tommaso Caravita, Pellegrino Musto, Norbert Pescosta, Fausto Rossini, Marco Vignetti, Mario Boccadoro	23
17	Treatment of Kasabach-Merritt syndrome by embolisation of a giant liver hemangioma 2001 ·American Journal of Hematology ·Atto Billio, Norbert Pescosta, (unknown), Giovanni Franco Zanon, Piergiorgio Gamba, Sergio Savastano, P Coser	14
18	Chronic neutrophilic leukemia evolving from polycythemia vera with multiple chromosome rearrangements: a case report. 2001 ·PubMed ·Atto Billio, (unknown), Enrico Morello, (unknown), Norbert Pescosta, P Coser	5
19	Epstein-Barr virus related hemophagocytic syndrome in a T-cell rich B-cell lymphoma 1999 ·Annals of Oncology ·Manfred Mitterer, Norbert Pescosta, (unknown), (unknown), (unknown), P Coser, Hans Knecht	11
20	Chronic active Epstein‐Barr virus disease in a case of persistent polyclonal B‐cell lymphocytosis 1995 ·British Journal of Haematology ·Manfred Mitterer, Norbert Pescosta, Falko Fend, Clara Larcher, Nadja Prang, Fritz Schwarzmann, P Coser, Hartwig P. Huemer	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact